Novo Nordisk Patent Suit Over Prandin Nixed
Mylan Pharmaceuticals Inc. has won its bid to dismiss a patent infringement suit brought by Novo Nordisk A/S over a generic version of diabetes drug Prandin....To view the full article, register now.
Already a subscriber? Click here to view full article